The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

U.S. House representatives heard the clinical lab industry plead yesterday for a reprieve from looming cuts as large as 15% ...

Amid rising interest in alternative medicine and growing skepticism of physicians, companies have begun providing a more ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...

Alison Wagonfeld will report to CEO Jensen Huang as marketing rises in importance at the AI chip maker. Beijing worries the $2.5 billion acquisition of startup Manus will encourage more entrepreneurs ...